Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 213

1.

Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention.

Farhan S, Vogel B, Baber U, Sartori S, Aquino M, Chandrasekhar J, Sorrentino S, Giustino G, Sharma M, Guedeney P, Rohla M, Bhandari R, Barman N, Sweeny J, Dangas G, Mehran R, Kini A, Sharma S.

Cardiorenal Med. 2019 Mar 7;9(3):160-167. doi: 10.1159/000494807. [Epub ahead of print]

PMID:
30844810
2.

Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry.

Colombo A, Chandrasekhar J, Aquino M, Ong TK, Sartori S, Baber U, Lee M, Iniguez A, Hajek P, Borisov B, Atzev B, Den Heijer P, Coufal Z, Hudec M, Mates M, Snyder C, Moalem K, Morrell D, Elmore F, Rowland S, Mehran R; MASCOT Investigators.

Int J Cardiol. 2019 May 15;283:67-72. doi: 10.1016/j.ijcard.2019.01.053. Epub 2019 Jan 21.

PMID:
30826192
3.

Deep learning for cardiovascular medicine: a practical primer.

Krittanawong C, Johnson KW, Rosenson RS, Wang Z, Aydar M, Baber U, Min JK, Tang WHW, Halperin JL, Narayan SM.

Eur Heart J. 2019 Feb 27. pii: ehz056. doi: 10.1093/eurheartj/ehz056. [Epub ahead of print]

PMID:
30815669
4.

Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock.

Atti V, Patel NJ, Kumar V, Tripathi B, Basir MB, Voeltz M, Baber U, Kini AS, Sharma SK, O'Neill WW, Bhatt DL.

Catheter Cardiovasc Interv. 2019 Feb 27. doi: 10.1002/ccd.28161. [Epub ahead of print]

PMID:
30811833
5.

Safety and Efficacy of Polymer-Free Drug-Eluting Stents.

Chiarito M, Sardella G, Colombo A, Briguori C, Testa L, Bedogni F, Fabbiocchi F, Paggi A, Palloshi A, Tamburino C, Margonato A, Pivato CA, Baber U, Calcagno S, Giordano A, Godino C, Stefanini GG.

Circ Cardiovasc Interv. 2019 Feb;12(2):e007311. doi: 10.1161/CIRCINTERVENTIONS.118.007311.

PMID:
30767663
6.

Impact of Discharge Location After Transcatheter Aortic Valve Replacement on 1-Year Outcomes in Women: Results From the WIN-TAVI Registry.

Mehilli J, Chandrasekhar J, Sartori S, Chieffo A, Petronio AS, Lefèvre T, Presbitero P, Capranzano P, Tchetche D, Iadanza A, Sardella G, Van Mieghem NM, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Jochheim D, Zadrozny M, Mikhail GW, Sharma S, Ferrer MC, Naber C, Kievit P, Moalem K, Baber U, Snyder C, Sharma M, Morice MC, Mehran R; Women’s INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) Investigators.

Can J Cardiol. 2019 Feb;35(2):199-207. doi: 10.1016/j.cjca.2018.11.035. Epub 2018 Dec 12.

PMID:
30760427
7.

Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.

Faggioni M, Baber U, Chandrasekhar J, Sartori S, Weintraub W, Rao SV, Vogel B, Claessen B, Kini A, Effron M, Ge Z, Keller S, Strauss C, Snyder C, Toma C, Weiss S, Aquino M, Baker B, Defranco A, Bansilal S, Muhlestein B, Kapadia S, Pocock S, Poddar KL, Henry TD, Mehran R.

Catheter Cardiovasc Interv. 2019 Jan 17. doi: 10.1002/ccd.28033. [Epub ahead of print]

PMID:
30656812
8.

Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes.

Schoos M, Power D, Baber U, Sartori S, Claessen B, Camaj A, Steg P, Ariti C, Weisz G, Witzenbichler B, Henry T, Cohen D, Antoniucci D, Krucoff M, Hermiller J, Gibson C, Chieffo A, Moliterno D, Colombo A, Pocock S, Dangas G, Mehran R.

Am J Cardiol. 2019 Mar 1;123(5):709-716. doi: 10.1016/j.amjcard.2018.11.051. Epub 2018 Dec 4.

PMID:
30612724
9.

Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry.

Moalem K, Baber U, Chandrasekhar J, Claessen BE, Sartori S, Aquino M, Dangas G, Iakovou I, Colombo A, Kini A, Gibson M, Krucoff M, Chieffo A, Moliterno D, Witzenbichler B, Pocock S, Mehran R.

Clin Res Cardiol. 2019 Jan 3. doi: 10.1007/s00392-018-1392-2. [Epub ahead of print]

PMID:
30607496
10.

Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.

Baber U, Leisman DE, Cohen DJ, Gibson CM, Henry TD, Dangas G, Moliterno D, Kini A, Krucoff M, Colombo A, Chieffo A, Sartori S, Witzenbichler B, Steg PG, Pocock SJ, Mehran R.

Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004945. doi: 10.1161/CIRCOUTCOMES.118.004945.

PMID:
30606052
11.

The Challenge of Diabetes Mellitus in the Contemporary Percutaneous Coronary Intervention Era: Are We Making Progress?

Baber U.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):2477-2479. doi: 10.1016/j.jcin.2018.10.027. No abstract available.

PMID:
30573058
12.

Left Main PCI With DES Versus CABG: Cautionary Note or Cause for Concern?

Baber U, Dangas GD.

J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2823-2825. doi: 10.1016/j.jacc.2018.09.058. No abstract available.

PMID:
30522645
13.

Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.

Guedeney P, Tchétché D, Petronio AS, Mehilli J, Sartori S, Lefèvre T, Presbitero P, Capranzano P, Iadanza A, Sardella G, Van Mieghem NM, Sorrentino S, Claessen BEPM, Chandrasekhar J, Vogel B, Kalkman DN, Meliga E, Dumonteil N, Fraccaro C, Trabattoni D, Mikhail G, Ferrer-Grazia MC, Naber C, Kievit P, Baber U, Sharma S, Morice MC, Chieffo A, Mehran R; WIN TAVI Investigators.

Catheter Cardiovasc Interv. 2018 Dec 4. doi: 10.1002/ccd.28012. [Epub ahead of print]

PMID:
30511802
14.

Predictors of side branch compromise in calcified bifurcation lesions treated with orbital atherectomy.

Barman N, Okamoto N, Ueda H, Chamaria S, Bhatheja S, Vengrenyuk Y, Gupta E, Sweeny J, Kapur V, Hasan C, Baber U, Moreno P, Sharma S, Kini AS.

Catheter Cardiovasc Interv. 2018 Dec 3. doi: 10.1002/ccd.27992. [Epub ahead of print]

PMID:
30511359
15.

Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention: Results from a large single-center prospective registry.

Guedeney P, Baber U, Claessen B, Aquino M, Camaj A, Sorrentino S, Vogel B, Farhan S, Faggioni M, Chandrasekhar J, Kalkman DN, Kovacic JC, Sweeny J, Barman N, Moreno P, Vijay P, Shah S, Dangas G, Kini A, Sharma S, Mehran R.

Am Heart J. 2019 Jan;207:10-18. doi: 10.1016/j.ahj.2018.09.001. Epub 2018 Sep 12.

PMID:
30404046
16.

Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention.

Faggioni M, Baber U, Chandrasekhar J, Sartori S, Claessen BE, Rao SV, Vogel B, Effron MB, Poddar K, Farhan S, Kini A, Weintraub W, Toma C, Sorrentino S, Weiss S, Snyder C, Muhlestein JB, Kapadia S, Keller S, Strauss C, Aquino M, Baker B, Defranco A, Pocock S, Henry T, Mehran R.

Int J Cardiol. 2019 Jan 15;275:31-35. doi: 10.1016/j.ijcard.2018.10.071. Epub 2018 Oct 25.

PMID:
30391067
17.

DNA Sequence Variation in ACVR1C Encoding the Activin Receptor-Like Kinase 7 Influences Body Fat Distribution and Protects Against Type 2 Diabetes.

Emdin CA, Khera AV, Aragam K, Haas M, Chaffin M, Klarin D, Natarajan P, Bick A, Zekavat SM, Nomura A, Ardissino D, Wilson JG, Schunkert H, McPherson R, Watkins H, Elosua R, Bown MJ, Samani NJ, Baber U, Erdmann J, Gupta N, Danesh J, Saleheen D, Gabriel S, Kathiresan S.

Diabetes. 2019 Jan;68(1):226-234. doi: 10.2337/db18-0857. Epub 2018 Nov 2.

PMID:
30389748
18.

Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation.

Sorrentino S, Baber U, Mehran R.

Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):192-194. doi: 10.1016/j.rec.2018.10.002. Epub 2018 Oct 30. English, Spanish. No abstract available.

PMID:
30389238
19.

Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.

Kalkman DN, Aquino M, Claessen BE, Baber U, Guedeney P, Sorrentino S, Vogel B, de Winter RJ, Sweeny J, Kovacic JC, Shah S, Vijay P, Barman N, Kini A, Sharma S, Dangas GD, Mehran R.

Eur Heart J. 2018 Dec 7;39(46):4101-4108. doi: 10.1093/eurheartj/ehy633.

PMID:
30358832
20.

Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis.

Varghese MJ, Bhatheja S, Baber U, Kezbor S, Chincholi A, Chamaria S, Buckstein M, Bakst R, Kini A, Sharma S.

Circ Cardiovasc Interv. 2018 Oct;11(10):e006832. doi: 10.1161/CIRCINTERVENTIONS.118.006832.

PMID:
30354630

Supplemental Content

Support Center